3221 related articles for article (PubMed ID: 6480158)
1. Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases.
Brunda MJ; Rosenbaum D; Stern L
Int J Cancer; 1984 Sep; 34(3):421-6. PubMed ID: 6480158
[TBL] [Abstract][Full Text] [Related]
2. Action of recombinant alpha interferon against experimental and spontaneous metastases in a murine model.
Ramani P; Balkwill FR
Int J Cancer; 1989 Jan; 43(1):140-6. PubMed ID: 2910826
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of human interferon-alpha A/D in mice (II). Activation of natural killer cells and suppression of metastasis].
Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):510-5. PubMed ID: 2988456
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent suppression of melanoma metastases and natural killer cell activation by interferon.
Ueda M; Mishima Y; Mojamdar M; Ichihashi M; Kita M; Kishida T
Arch Dermatol Res; 1986; 278(4):329-34. PubMed ID: 3740943
[TBL] [Abstract][Full Text] [Related]
5. Interaction of recombinant interferons with recombinant interleukin-2: differential effects on natural killer cell activity and interleukin-2-activated killer cells.
Brunda MJ; Tarnowski D; Davatelis V
Int J Cancer; 1986 May; 37(5):787-93. PubMed ID: 2422129
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of intravascular mouse melanoma dissemination by recombinant human interferon alpha A/D.
Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N
Jpn J Cancer Res; 1986 Jan; 77(1):80-4. PubMed ID: 3082819
[TBL] [Abstract][Full Text] [Related]
7. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
Kalland T
Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the antitumor effect of two types of murine recombinant interferons, (beta) and (gamma), against B16-F10 melanoma.
Sakurai M; Iigo M; Tamura T; Otsu A; Sasaki Y; Nakano H; Nakagawa K; Minato K; Ohe Y; Saijo N
Cancer Immunol Immunother; 1988; 26(2):109-13. PubMed ID: 3129191
[TBL] [Abstract][Full Text] [Related]
9. In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells.
Brunda MJ; Bellantoni D; Sulich V
Int J Cancer; 1987 Sep; 40(3):365-71. PubMed ID: 3497883
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of murine recombinant interferon (beta) on the pulmonary metastasis of B-16 melanoma.
Sakurai M; Iigo M; Ozaki A; Jett JR; Sasaki Y; Hoshi A; Saijo N
Jpn J Cancer Res; 1986 Aug; 77(8):774-81. PubMed ID: 3093426
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of recombinant murine interferon-gamma and human interferon-alpha A/D(Bgl) administered in concert and their influence on natural killer cell function in mice.
Chen SA; Shalaby MR; Crase DR; Palladino MA; Baughman RA
J Interferon Res; 1988 Oct; 8(5):597-608. PubMed ID: 3148670
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases.
Hirschowitz EA; Crystal RG
Am J Respir Cell Mol Biol; 1999 May; 20(5):935-41. PubMed ID: 10226063
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of hematogenous metastases in a murine model by natural killer cells.
Richie JP
Surgery; 1984 Aug; 96(2):133-8. PubMed ID: 6463854
[TBL] [Abstract][Full Text] [Related]
14. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.
Rosenberg SA; Mulé JJ; Spiess PJ; Reichert CM; Schwarz SL
J Exp Med; 1985 May; 161(5):1169-88. PubMed ID: 3886826
[TBL] [Abstract][Full Text] [Related]
15. [Direct and indirect antitumor effect of murine recombinant interferons].
Sakurai M; Iigo M; Sasaki Y; Hoshi A; Saijo N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):889-95. PubMed ID: 3105463
[TBL] [Abstract][Full Text] [Related]
16. Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.
Mazumder A; Rosenberg SA
J Exp Med; 1984 Feb; 159(2):495-507. PubMed ID: 6141211
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor efficacy in mice by combination treatment with interleukin-1 alpha and interferon-alpha.
Brunda MJ; Wright RB; Luistro L; Harbison ML; Anderson TD; McIntyre KW
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):233-41. PubMed ID: 8061895
[TBL] [Abstract][Full Text] [Related]
18. Human interferons inhibit experimental metastases of a human melanoma cell line in nude mice.
Ramani P; Balkwill FR
Br J Cancer; 1988 Sep; 58(3):350-4. PubMed ID: 2460119
[TBL] [Abstract][Full Text] [Related]
19. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
[TBL] [Abstract][Full Text] [Related]
20. The effect of interferon on experimental metastases in immunocompetent and immunodeficient mice.
Ramani P; Hart IR; Balkwill FR
Int J Cancer; 1986 Apr; 37(4):563-8. PubMed ID: 3485583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
